INmune Bio stock price
NASDAQ:INMB · Nasdaq · Healthcare · sector #16$1.61+0.63%Oct 21 close
Loading chart…
INmune Bio's chart data is dated 2026-10-21. There is no active technical signal. There are 4 published signal records.
INmune Bio last closed at $1.61 (+0.63%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -2.3×. Its overall grade ranks 336 of 727 stocks in Healthcare.
About this company
INmune Bio last closed at $1.61 (+0.63%) on 2026-10-21. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B · 336/727
Valuation grade A-
Related stocks
- AbbVieCompetitor
- AmgenCompetitor
- Bristol Myers SquibbCompetitor
About INmune Bio
- What technical signals does INmune Bio (INMB) have?
- INmune Bio current technical signals: no active technical signal.
- Is INmune Bio a cup-and-handle pattern?
- No. INmune Bio has no valid Cup signal right now.
- What published figures are available for INmune Bio?
- Market cap: $42.8M. Trailing 12 months PER: -2.3×. Latest quarter PBR: 2.11×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-22 dataset
Turn what you saw on this name into a strategy
Ask Q about INmune Bio, or open the plan table on the main site.
Ask Q about INmune Bio.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy